We always strive to do more in order to positively impact our patients consumers, employees, communities as well as our shareholders. We firmly believed that doing business with a conscience is integral in order to sustain our business success.
LATEST
28 NOVEMBER 2024
Pharmaniaga Berhad (Pharmaniaga) ramps up its Going Green programme with the launch of its latest renewable energy initiative through Solar PV System Project in collaboration with Cenergi SEA Berhad (Cenergi).
26 NOVEMBER 2024
Demonstrating further progress in its strong recovery, Pharmaniaga Berhad (Pharmaniaga) today reported improved results for its third quarter ended 30 September 2024 (Q3 FY2024), with Profit After Tax (PAT) reaching RM101.3 million compared with a loss of RM49.0 million in the same quarter last year (Q3 FY2023).
10 OCTOBER 2024
Pharmaniaga Berhad (Pharmaniaga) is pleased to announce the appointment of Messrs Ernst & Young (EY) as its new external auditor, effective 9 October 2024. EY replaces Messrs PricewaterhouseCoopers (PwC), which has resigned following a formal written notice served to the Group on 20 September 2024.
1 OCTOBER 2024
Pharmaniaga Berhad (Pharmaniaga) is pleased to announce the appointment of Dato’ Seri Abdul Razak Jaafar as its new Independent Non-Executive Chairman, effective today. He succeeds Izaddeen Daud, who has held the position since February 2023, and as part of this strategic leadership transition, Izaddeen has been redesignated as Non-Independent Non-Executive Director.